Muhammad Omer Iqbal
- Molecular Medicine top 10%
-
- Nanoparticle-Based Drug Delivery 3
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 2
-
- Phytochemicals and Antioxidant Activities 3
-
- Chemotherapy-induced organ toxicity mitigation 4
-
- Natural Antidiabetic Agents Studies 3
-
- Nanoparticles: synthesis and applications 3
-
- Pharmacological Effects and Toxicity Studies 3
-
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Esam Bashir YahyaMuhammad NaeemAbu HazafaAmirul Al‐Ashraf AbdullahFauziah JummaatN. G. OlaiyaH. P. S. Abdul KhalilSummya Rashid
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)Molecules (4 papers)
- Partner nations
- ChinaPakistanSaudi Arabia
In The Last Decade
Muhammad Omer Iqbal
37 papers receiving 446 citations
Peers
Comparison fields: 5 of 100
- Molecular Medicine 37
- Biomaterials 80
- Pharmaceutical Science 34
- Biochemistry 30
- Complementary and alternative medicine 38
Countries citing papers authored by Muhammad Omer Iqbal
This map shows the geographic impact of Muhammad Omer Iqbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Omer Iqbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Omer Iqbal more than expected).
Fields of papers citing papers by Muhammad Omer Iqbal
This network shows the impact of papers produced by Muhammad Omer Iqbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Omer Iqbal. The network helps show where Muhammad Omer Iqbal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muhammad Omer Iqbal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 23 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 63 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 22 | |
| 14 | 2022 | 20 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 69 | |
| 17 | 2021 | 16 | |
| 18 | 2021 | 55 | |
| 19 | 2021 | 11 | |
| 20 | SOME PHYSIOCHEMICAL RESPONSES OF BACOPA MONNIERA (L.) WETTST. CULTURES TO COPPER TOXICITY | 1999 | 3 |
About Muhammad Omer Iqbal
Muhammad Omer Iqbal is a scholar working on Medical Laboratory Technology, Complementary and alternative medicine and Biochemistry, having authored 39 papers that have together received 458 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Natural Antidiabetic Agents Studies (3 papers), Nanoparticles: synthesis and applications (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Advanced Drug Delivery Systems (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Molecular Medicine (37 citations), Biomaterials (80 citations) and Pharmaceutical Science (34 citations). Muhammad Omer Iqbal has collaborated with scholars based in China, Pakistan and Saudi Arabia. Frequent co-authors include Esam Bashir Yahya, Muhammad Naeem, Abu Hazafa, Amirul Al‐Ashraf Abdullah, Fauziah Jummaat, N. G. Olaiya, H. P. S. Abdul Khalil, Summya Rashid, Mateusz Kciuk and Usman Javaid. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.